Last reviewed · How we verify

Irrigation with Clindamycin solution

Hospital General Universitario Elche · Phase 3 active Small molecule

Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby reducing pathogenic bacterial growth in irrigated surgical or wound sites.

Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby reducing pathogenic bacterial growth in irrigated surgical or wound sites. Used for Surgical site infection prophylaxis via irrigation, Wound irrigation to reduce bacterial contamination.

At a glance

Generic nameIrrigation with Clindamycin solution
Also known asIrrigation of the surgical bed with Clindamycin solution
SponsorHospital General Universitario Elche
Drug classLincosamide antibiotic
TargetBacterial 50S ribosomal subunit
ModalitySmall molecule
Therapeutic areaInfectious Disease / Surgery
PhasePhase 3

Mechanism of action

Clindamycin works by penetrating bacterial cells and binding to the bacterial 50S ribosomal subunit, which prevents peptide bond formation and halts protein synthesis. When used as an irrigation solution, it delivers high local antibiotic concentrations directly to the surgical or wound site, reducing bacterial colonization and infection risk. This topical/local delivery approach minimizes systemic exposure while maintaining effective antimicrobial activity against susceptible gram-positive and anaerobic organisms.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: